DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...
The city is poised to effectively sell TMH to FSU for its ambitious FSU Health program. What does this mean for Tallahassee ...
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsBrian Kearns - Senior Vice President of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results